#United States #Los Angeles #Schall Law Firm #Securities Fraud #Cardlytics

CDLX Investors Have Opportunity to Lead Cardlytics, Inc. Securities Fraud Lawsuit

On January 30, 2025, the Schall Law Firm, renowned for its focus on shareholder rights, issued a reminder for investors holding shares in Cardlytics, Inc. (NASDAQ: CDLX) about an ongoing class action lawsuit. This lawsuit centers on alleged violations of specific provisions of the Securities Exchange Act of 1934, specifically sections 10(b) and 20(a), as well as Rule 10b-5, which is enforced by the U.S. Securities and Exchange Commission (SEC).

The class period in question extends from March 14, 2024, to August 7, 2024. Investors who bought Cardlytics securities during this time frame are encouraged to reach out to the Schall Law Firm before the deadline of March 25, 2025. For shareholders who have experienced financial losses due to this situation, the legal firm is providing an opportunity to join the lawsuit without charge, potentially enabling them to recover their investment losses.

Interested investors can initiate contact by calling Brian Schall at the Law Firm's office located in Los Angeles, or by visiting their official website to further discuss their legal rights and options. It is important to note that the court has yet to certify the class, which means that investors who choose not to act during this period are considered absent from the lawsuit.

As noted in the complaint, Cardlytics is accused of making misleading statements that inflated investor expectations. Despite a noteworthy surge in consumer incentives linked to increased consumer engagement, the company's revenue growth was not aligned with consumer behavior, indicating a failure to boost billings at the same rate. The revised Ads Decision Engine used by Cardlytics is cited as a principal contributor to 'under-delivery' against budgetary estimates, which ultimately misled investors regarding the company's financial health.

The public was not apprised of the risks stemming from slowing revenue growth in a timely manner, leading to significant investor losses when the realities of the situation emerged. Following the revelation of the complete and potentially damaging picture surrounding Cardlytics’ operations, affected investors were left to grapple with the erosion of their investments, underscoring the stakes involved in corporate transparency and responsibility.

The Schall Law Firm specializes in representing shareholders worldwide and actively seeks to uphold investor rights through litigation. They have a proven track record of handling securities class action lawsuits and are committed to guiding investors through the complexities of the legal process when corporate malfeasance occurs.

For any investors feeling the impact of this situation, now is an opportune moment to engage with legal professionals who understand the nuances of securities law and class actions. As this case progresses, staying informed and involved could be critical in securing potential reparations for losses experienced during the class period. With the involvement of established legal experts, shareholders stand a better chance of navigating the legal landscape, achieving justice, and potentially recouping losses incurred during the period of alleged misconduct.

Conclusion

In situations where investor rights are at stake, as seen with the Cardlytics securities fraud claims, it is essential to seek legal guidance promptly. Investors should not hesitate to participate in class action suits that offer a pathway to recover losses imposed by companies that fail to uphold transparency and accountability in their operational disclosures.

For further information about participating in this class action, visit the Schall Law Firm website or contact them directly at their Los Angeles location.